Suppr超能文献

兴奋剂使用障碍患者12步戒酒互助会出勤和参与情况的预测因素

Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.

作者信息

Hatch-Maillette Mary, Wells Elizabeth A, Doyle Suzanne R, Brigham Gregory S, Daley Dennis, DiCenzo Jessica, Donovan Dennis, Garrett Sharon, Horigian Viviana E, Jenkins Lindsay, Killeen Therese, Owens Mandy, Perl Harold I

机构信息

University of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105; University of Washington School of Medicine, Department of Psychiatry and Behavioral Sciences, 1959 NE Pacific St., Seattle, WA 98105.

University of Washington Alcohol and Drug Abuse Institute, 1107 NE 45th St., Suite 120, Seattle, WA 98105; University of Washington School of Social Work, 4101 15th Ave NE, Seattle, WA 98105.

出版信息

J Subst Abuse Treat. 2016 Sep;68:74-82. doi: 10.1016/j.jsat.2016.06.007. Epub 2016 Jun 16.

Abstract

OBJECTIVE

Few studies have examined the effectiveness of 12-step peer recovery support programs with drug use disorders, especially stimulant use, and it is difficult to know how outcomes related to 12-step attendance and participation generalize to individuals with non-alcohol substance use disorders (SUDs).

METHOD

A clinical trial of 12-step facilitation (N=471) focusing on individuals with cocaine or methamphetamine use disorders allowed examination of four questions: Q1) To what extent do treatment-seeking stimulant users use 12-step programs and, which ones? Q2) Do factors previously found to predict 12-step participation among those with alcohol use disorders also predict participation among stimulant users? Q3) What specific baseline "12-step readiness" factors predict subsequent 12-step participation and attendance? And Q4) Does stimulant drug of choice differentially predict 12-step participation and attendance?

RESULTS

The four outcomes variables, attendance, speaking, duties at 12-step meetings, and other peer recovery support activities, were not related to baseline demographic or substance problem history or severity. Drug of choice was associated with differential days of Alcoholics Anonymous (AA) and Narcotics Anonymous (NA) attendance among those who reported attending, and cocaine users reported more days of attending AA or NA at 1-, 3- and 6-month follow-ups than did methamphetamine users. Pre-randomization measures of perceived benefit of 12-step groups predicted 12-step attendance at 3- and 6-month follow-ups. Pre-randomization 12-step attendance significantly predicted number of other self-help activities at end-of-treatment, 3- and 6-month follow-ups. Pre-randomization perceived benefit and problem severity both predicted number of self-help activities at end-of-treatment and 3-month follow-up. Pre-randomization perceived barriers to 12-step groups were negatively associated with self-help activities at end-of-treatment and 3-month follow-up. Whether or not one participated in any duties was predicted at all time points by pre-randomization involvement in self-help activities.

CONCLUSIONS

The primary finding of this study is one of continuity: prior attendance and active involvement with 12-step programs were the main signs pointing to future involvement. Limitations and recommendations are discussed.

摘要

目的

很少有研究探讨12步同伴康复支持项目对药物使用障碍(尤其是兴奋剂使用障碍)的有效性,而且很难知道与参加和参与12步项目相关的结果如何推广到非酒精物质使用障碍(SUDs)个体。

方法

一项针对可卡因或甲基苯丙胺使用障碍个体的12步促进临床试验(N = 471),可以研究四个问题:问题1)寻求治疗的兴奋剂使用者在多大程度上使用12步项目,以及使用哪些项目?问题2)先前发现的预测酒精使用障碍者参与12步项目的因素,是否也能预测兴奋剂使用者的参与情况?问题3)哪些特定的基线“12步准备度”因素能预测随后参与和出席12步项目的情况?问题4)首选的兴奋剂药物是否能不同程度地预测参与和出席12步项目的情况?

结果

四个结果变量,即出席情况、发言、在12步会议中的职责以及其他同伴康复支持活动,与基线人口统计学或物质问题病史或严重程度无关。在报告参加的人群中,首选药物与参加匿名戒酒会(AA)和匿名戒毒会(NA)的天数差异有关,在1个月、3个月和6个月的随访中,可卡因使用者报告参加AA或NA的天数比甲基苯丙胺使用者更多。随机分组前对12步团体感知益处的测量,能预测3个月和6个月随访时的12步出席情况。随机分组前的12步出席情况显著预测了治疗结束时、3个月和6个月随访时其他自助活动的次数。随机分组前的感知益处和问题严重程度,都能预测治疗结束时和3个月随访时自助活动的次数。随机分组前对12步团体的感知障碍与治疗结束时和3个月随访时的自助活动呈负相关。在所有时间点,随机分组前参与自助活动都能预测是否参与任何职责。

结论

本研究的主要发现是具有连续性:先前参加并积极参与12步项目是未来参与的主要标志。讨论了局限性和建议。

相似文献

1
Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.
J Subst Abuse Treat. 2016 Sep;68:74-82. doi: 10.1016/j.jsat.2016.06.007. Epub 2016 Jun 16.
3
'Tweaking 12-Step': the potential role of 12-Step self-help group involvement in methamphetamine recovery.
Addiction. 2007 Apr;102 Suppl 1:121-9. doi: 10.1111/j.1360-0443.2007.01773.x.
4
Age differences in outcomes among patients in the "Stimulant Abuser Groups to Engage in 12-Step" (STAGE-12) intervention.
J Subst Abuse Treat. 2018 Jan;84:21-29. doi: 10.1016/j.jsat.2017.10.012. Epub 2017 Oct 28.
5
Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.
J Subst Abuse Treat. 2013 Jan;44(1):103-14. doi: 10.1016/j.jsat.2012.04.004. Epub 2012 May 31.
7
Twelve-step and mutual-help programs for addictive disorders.
Psychiatr Clin North Am. 1999 Jun;22(2):425-46. doi: 10.1016/s0193-953x(05)70085-x.
8
Factors associated with attendance in 12-step groups (Alcoholics Anonymous/Narcotics Anonymous) among adults with alcohol problems living with HIV/AIDS.
Drug Alcohol Depend. 2011 Jan 15;113(2-3):165-71. doi: 10.1016/j.drugalcdep.2010.07.021. Epub 2010 Sep 15.
9
Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial.
Drug Alcohol Depend. 2012 Nov 1;126(1-2):131-7. doi: 10.1016/j.drugalcdep.2012.05.004. Epub 2012 Jun 6.
10
Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
Int J Drug Policy. 2017 Nov;49:32-40. doi: 10.1016/j.drugpo.2017.07.009. Epub 2017 Sep 6.

引用本文的文献

3
Current and Emerging Treatments for Methamphetamine Use Disorder.
Curr Neuropharmacol. 2021;19(12):2077-2091. doi: 10.2174/1570159X19666210803091637.

本文引用的文献

3
A Combined Group and Individual 12-Step Facilitative Intervention Targeting Stimulant Abuse in the NIDA Clinical Trials Network: STAGE-12.
J Groups Addict Recover. 2011;6(3):228-244. doi: 10.1080/1556035X.2011.597196. Epub 2011 Aug 29.
4
Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial.
Drug Alcohol Depend. 2012 Nov 1;126(1-2):224-31. doi: 10.1016/j.drugalcdep.2012.05.019. Epub 2012 Jun 12.
5
Does active referral by a doctor or 12-Step peer improve 12-Step meeting attendance? Results from a pilot randomised control trial.
Drug Alcohol Depend. 2012 Nov 1;126(1-2):131-7. doi: 10.1016/j.drugalcdep.2012.05.004. Epub 2012 Jun 6.
6
Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.
J Subst Abuse Treat. 2013 Jan;44(1):103-14. doi: 10.1016/j.jsat.2012.04.004. Epub 2012 May 31.
7
Determining the relative importance of the mechanisms of behavior change within Alcoholics Anonymous: a multiple mediator analysis.
Addiction. 2012 Feb;107(2):289-99. doi: 10.1111/j.1360-0443.2011.03593.x. Epub 2011 Sep 19.
8
Twelve-step program attendance and polysubstance use: interplay of alcohol and illicit drug use.
J Stud Alcohol Drugs. 2011 Sep;72(5):864-71. doi: 10.15288/jsad.2011.72.864.
9
Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.
Am J Drug Alcohol Abuse. 2011 Sep;37(5):400-7. doi: 10.3109/00952990.2011.596975.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验